需要改善遗传学护理的可及性，以解决ATTRv 淀粉样变性中的健康不平等问题。
Improved Access to Genetics Care is Needed to Address Health Inequities in ATTRv Amyloidosis.
机构信息
The School of Medicine at Mount Sinai, New York, NY (L.L.).
The Cardiac Amyloidosis Program, Columbia University Irving Medical Center, New York Presbyterian Hospital (M.S.M.).
出版信息
Circulation. 2024 Oct;150(14):1072-1074. doi: 10.1161/CIRCULATIONAHA.124.070525. Epub 2024 Sep 30.
Abstract
Improved access to genetics care through eased regulations on genetic counselors and telehealth practices can ameliorate inequities in ATTRv.
摘要
通过放宽对遗传咨询师和远程医疗实践的监管，改善获取遗传学护理的机会，可以改善ATTRv 中的不平等现象。
相似文献
1
Improved Access to Genetics Care is Needed to Address Health Inequities in ATTRv Amyloidosis.需要改善遗传学护理的可及性，以解决ATTRv 淀粉样变性中的健康不平等问题。
Circulation. 2024 Oct;150(14):1072-1074. doi: 10.1161/CIRCULATIONAHA.124.070525. Epub 2024 Sep 30.
2
Hereditary transthyretin amyloidosis overview.遗传性转甲状腺素蛋白淀粉样变性概述。
Neurol Sci. 2022 Dec;43(Suppl 2):595-604. doi: 10.1007/s10072-020-04889-2. Epub 2020 Nov 14.
3
Amyloid Neuropathy: From Pathophysiology to Treatment in Light-Chain Amyloidosis and Hereditary Transthyretin Amyloidosis.淀粉样变神经病：轻链淀粉样变和遗传性转甲状腺素蛋白淀粉样变中的病理生理学到治疗。
Ann Neurol. 2024 Sep;96(3):423-440. doi: 10.1002/ana.26965. Epub 2024 Jun 24.
4
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.遗传性转甲状腺素淀粉样变性症的职业治疗服务可及性。
Int J Environ Res Public Health. 2022 Apr 7;19(8):4464. doi: 10.3390/ijerph19084464.
5
Hereditary Transthyretin Amyloidosis and the Impact of Classic and New Treatments on Kidney Function: A Review.遗传性转甲状腺素蛋白淀粉样变性病和经典及新型治疗方法对肾功能的影响：综述。
Am J Kidney Dis. 2024 Aug;84(2):224-231. doi: 10.1053/j.ajkd.2024.01.527. Epub 2024 Mar 12.
6
Identification and management of gastrointestinal manifestations of hereditary transthyretin amyloidosis: Recommendations from an Italian group of experts.遗传性转甲状腺素蛋白淀粉样变性的胃肠道表现的识别和管理：意大利专家组的建议。
Dig Liver Dis. 2024 Jun;56(6):1014-1020. doi: 10.1016/j.dld.2023.11.025. Epub 2023 Dec 17.
7
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.转甲状腺素蛋白淀粉样变性伴胃肠道表现的诊断与管理建议。
Eur J Gastroenterol Hepatol. 2021 May 1;33(5):613-622. doi: 10.1097/MEG.0000000000002030.
8
First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.首例挪威遗传性ATTR 淀粉样变伴新型转甲状腺素蛋白变异。
Scand Cardiovasc J. 2023 Dec;57(1):2174269. doi: 10.1080/14017431.2023.2174269.
9
The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis.遗传性转甲状腺素蛋白（ATTRv）淀粉样变性的患者就诊过程。
Orphanet J Rare Dis. 2021 Jan 11;16(1):25. doi: 10.1186/s13023-020-01623-1.
10
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.神经丝轻链，系统性淀粉样变多发性神经病的生物标志物。
Amyloid. 2021 Mar;28(1):50-55. doi: 10.1080/13506129.2020.1815696. Epub 2020 Sep 4.
本文引用的文献
1
Cardiovascular Burden of the V142I Transthyretin Variant.载脂蛋白 V142I 变异的心血管负担。
JAMA. 2024 Jun 4;331(21):1824-1833. doi: 10.1001/jama.2024.4467.
2
Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases.遗传性心血管疾病中指南指导下基因检测的真实世界应用情况
Front Cardiovasc Med. 2023 Oct 17;10:1272433. doi: 10.3389/fcvm.2023.1272433. eCollection 2023.
3
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.2023年美国心脏病学会关于心脏淀粉样变性患者综合多学科护理的专家共识决策路径：美国心脏病学会解决方案集监督委员会报告
J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126. doi: 10.1016/j.jacc.2022.11.022. Epub 2023 Jan 23.
4
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.电话与当面传递种系癌症基因检测结果的随机非劣效性试验
J Natl Cancer Inst. 2018 Sep 1;110(9):985-993. doi: 10.1093/jnci/djy015.
5
Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association.提高心血管遗传学素养：美国心脏协会的科学声明
Circ Cardiovasc Genet. 2016 Oct;9(5):448-467. doi: 10.1161/HCG.0000000000000031. Epub 2016 Sep 26.
Zotero 插件